Dana HARB et al. 2014. The Off-Label Use of Rituximab for the Management of Inflammatory Disorders: American University of Beirut Medical Center Experience. Archives of Rheumatology. 29, 3 (Sep. 2014), 194–202. DOI:https://doi.org/10.5606/ArchRheumatol.2014.3855.